Ireland’s Largest Independent Bioanalytical Laboratory Reports Swift Implementation and Validation of InnaPhase Corporation’s Watson™ LIMS

InnaPhase Corporation, a world-leading provider of enterprise Laboratory Information Management System (LIMS) solutions, today announced that BioClin Research Laboratories Ltd., a leading contract research organization (CRO) located in Athlone, Ireland, has successfully implemented and validated Watson™ LIMS in its bioanalytical facility.

“Implementation of an industry-standard such as Watson LIMS has significantly improved throughput of our data and is a huge step in the automation of our bioanalytical laboratory,” said Brian McKenna, Ph.D., Scientific Director of BioClin. “The system allows us to deliver accurate, high-quality results to our clients in the shortest possible timeframe.”

Watson is a purpose-built LIMS designed specifically to support DMPK/Bioanalytical studies in drug development. It was developed by InnaPhase in conjunction with the world’s major pharmaceutical companies to accelerate bioanalysis and sample management in drug development.

“Our strategy in providing purpose-built LIMS solutions is to help our customers deploy the LIMS as rapidly as possible because their business demands it,” said Jo Webber, Ph.D., President and Chief Executive Officer of InnaPhase Corporation. “Watson and the other LIMS in our Pharma LIMS™ Suite – Newton™ for QC and Galileo™ for in vitro testing – are designed with more pharma-specific functionality than generic information management systems and therefore can be implemented more quickly, and supported more easily.”

BioClin Research Laboratories is Ireland’s largest, independent, GLP-certified bioanalytical laboratory specializing in the analysis of biological samples for the Pharmaceutical, Veterinary, Biotechnology and Medical Device industries.

InnaPhase Corporation provides 18 of the world’s top 20 pharmaceutical organizations with its products and services. The Pharma LIMS™ Suite is a series of purpose built LIMS applications for the pharmaceutical industry and is designed to operate in a 21 CFR Part 11 compliant environment. The Pharma LIMS Suite includes: Newton™ LIMS for batch release, quality control, formulation, stability and analytical development; Watson™ LIMS for pre-clinical and clinical bioanalysis; and Galileo™ LIMS for In Vitro testing. InnaPhase also supplies LabManager iLIMS and Thompson™ LIMS as well as the PeakPro chromatography automation system. InnaPhase has locations in the United States, the United Kingdom, Germany, The Netherlands and distribution centers in India and Japan.

For more information, see InnaPhase Corporation on the World Wide Web at www.innaphase.com